388
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Efficacy of Montelukast and Airway Mast Cell Profiles in Patients with Cough Variant Asthma

, M.D., , M.D., , M.D., , Ph.D., , M.D. & , M.D.
Pages 243-250 | Published online: 02 Jul 2009

References

  • Global strategy for asthma management and prevention 2003. National Institutes of Health, New York 2003; 115–119
  • Brightling C E, Bradding P, Symon F A, Holgate S T, Wardlaw A J, Pavord I D. Mast -cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699–1705
  • Henderson W R, Jr. Eicosanoids and lung inflammation. Am Rev Respir Dis 1987; 135: 1176–1185
  • Barnes P J, Chung K F, Page C P. Inflammatory mediators and asthma. Pharmacol Rev 1988; 40: 49–84
  • Dahlen S E, Hedqvist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288: 484–486
  • Jones T R, Davies C, Daniel E E. Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscle. Can J Physiol Pharmacol 1982; 60: 638–643
  • Panettieri R A, Tan E M, Ciocca V, Luttmann M A, Leonard T B, Hay D W. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998; 19: 453–461
  • Minoguchi K, Kohno Y, Minoguchi H, Kihara N, Sano Y, Yasuhara H, Adachi M. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest 2002; 121: 732–738
  • Persson C G. Role of plasma exudation in asthmatic airways. Lancet 1986; 2: 1126–1129
  • Corrao W M, Braman S S, Irwin R S. Chronic cough as the sole presenting manifestation of bronchial asthma. New Engl J Med 1979; 300: 633–637
  • Braman S S, Corrao W M. Chronic cough diagnosis and treatment. Primary Care 1958; 12: 217–225
  • Koh Y Y, Jeong J H, Park Y, Kim C K. Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness. Eur Respir J 1999; 14: 302–308
  • Iwanaga T, Inuzuka S, Takahashi N, Kishikawa R, Yokota K, Ikeda T, Hirose T, Tsurutani H, Nishima S. Cough variant asthma among patients with chronic persistent cough and its clinical outcome. Arerugi 1998; 47: 457–461
  • Puolijoki H, Lahdensuo A. Chronic cough as a risk indicator of broncho-pulmonary disease. Eur J Respir Dis 1987; 71: 77–85
  • Makino S, Ikemori R, Fukuda T, Motojima S, Namai S, Toda M, Yamai T, Yamada G, Yukawa T. Clinical evaluation of standard method of acetylcholine inhalation test in bronchial asthma. Arerugi 1984; 33: 167–175, [Article in Japanese.]
  • British Thoracic Society Bronchoscopy Guidelines Committee. British Thoracic Society Guidelines on diagnostic flexible bronchoscopy. Thorax 2001; 56(suppl I)i1–i21
  • Niimi A, Matsumoto H, Minakuchi M, Masanori K. Ryoichi A. Airway remodeling in patients with cough variant asthma. Lancet 2000; 356: 564–565
  • Knol E F, Hoogerwerf M, Mul F PJ, Kujipers T W, Roos D. Analysis using the myeloid panel mAb of purified basophils obtained from human blood: changes in expression during degranulation. Leucocyte Typing V, S F Schlossman, et al. Oxford University Press, New York 1995; 1049–1051
  • Krauth M T, Majlesi Y, Florian S, Bohm A, Hauswirth A W, Ghannadan M, Wimazal F, Raederer M, Wrba F, Valent P. Cell surface membrane antigen phenotype of human gastrointestinal mast cells. Int Arch Allergy Immunol 2005; 138: 111–120
  • Grützkan A, Smorodchenko A, Lippert U, Kirchhof Artuc M, Henz B M. LAMP-1 and LAMP-2, but not LAMP-3 are reliable markers for activation-induced secretion of human mast cells. Cytometry Part A 2004; 31A: 62–68
  • Furumo T, Teshima R, Kitani S, Sawada J, Nakanishi M. Surface expression of CD63 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem Biphys Res Commun 1996; 219: 740–744
  • Valent P, Schernthaner G-H, Sperr W R, Fritsch G, Agis H, Wilheim M, Burring H J, Orfao A, Escribano L. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev 2001; 179: 74–81
  • Kraft S, Fleming T, Billingsley J M, Lin S-Y, Jouvin M-H, Storz P, Kinet J-P. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J Exp Med 2005; 201: 385–396
  • Yasuda M, Hasunuma Y, Adachi H, Sekine C, Sakanishi T, Hashimoto H, Yagita C RAH, Okumura K. Expression and function of fibronectin binding integrins on rat mast cells. Int. Immunol 1995; 7: 251–258
  • Minoguchi K, Kohno Y, Minoguchi H, Kihara N, Sano Y, Yasuhara H, Adachi M. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest 2002; 121: 732–738
  • Nakamura Y, Hoshino M, Sim J J, Ishii K, Hosaka K, Sakamoto T. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 1998; 53: 835–841
  • Widdicombe J G. Neurophysiology of the cough reflex. Eur Respir J 1995; 8: 1193–1202
  • Lee S Y, Kim M K, Shin C, Shim J J, Kim H K, Kang K H, Yoo S H, In K H. Substance P-Immunoreactive nerves in endobronchial biopsies in cough-variant asthma and classic asthma. Respiration 2003; 70: 49–53
  • McAlexander M A, Myers A C, Undem B J. Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. J Pharmacol Exp Ther 1998; 285: 602–607
  • Ellis J L, Undem B J. Role of peptidoleukotrienes in capsaicine-sensitive sensory fiber-mediated responses in guinea-pig airways. J Physiol 1991; 436: 469–484
  • Kawana S, Liang Z, Nagano M, Suzuki H. Role of substance P in stress-derived degranulation of dermal mast cells in mice. J Dermatol Sci 2006; 42: 47–54
  • Oskeritzian C A, Zhao W, Min H-K, Xia H-Z, Pozez A, Kiev J, Schwartz L B. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol 2005; 115: 1162–1168
  • Bloomquist E I, Kream R M. Leukotriene D4 acts in part to contract guinea pig ileum smooth muscle by releasing substance P. J Pharmacol Exp Ther 1987; 240: 523–528

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.